Kura Oncology, Inc. KURA
- darlifarnib — Renal Cell Carcinoma Phase 1
- darlifarnib — Non-Small Cell Lung Cancer Phase 1
- darlifarnib — Colorectal Cancer Phase 1
- darlifarnib — Pancreatic Ductal Adenocarcinoma Phase 1
mTORC1 (1 companies · 4 programs)
Companies with an active program directed at mTORC1.